Abstract
Drug development is a high cost and laborious process, requiring a number of tests until a drug is made available in the market. Therefore, the use of methods to screen large number of molecules with less cost is crucial for faster identification of hits and leads. One strategy to identify drug-like molecules is the search for molecules able to interfere with a protein function, since protein interactions control most biological processes. Ideally the use of in silico screenings would make drug development faster and less expensive. Currently, however, the confirmation of biological activity is still needed. Due to the complexity of the task of drug discovery, an integrated and multi-disciplinary approach is ultimately required. Here we discuss examples of drugs developed through a combination of in silico and in vitro strategies. The potential use of these methodologies for the identification of active compounds as well as for early toxicity and bioavailability is also reviewed.
Keywords: Protein target, drug development, in silico screening, in vitro screening, pharmacokinetics
Current Drug Targets
Title: In Silico and In Vitro: Identifying New Drugs
Volume: 9 Issue: 12
Author(s): Ivani Pauli, Luis Fernando Saraiva Macedo Timmers, Rafael Andrade Caceres, Milena Botelho Pereira Soares and Walter Filgueira de Azevedo Jr.
Affiliation:
Keywords: Protein target, drug development, in silico screening, in vitro screening, pharmacokinetics
Abstract: Drug development is a high cost and laborious process, requiring a number of tests until a drug is made available in the market. Therefore, the use of methods to screen large number of molecules with less cost is crucial for faster identification of hits and leads. One strategy to identify drug-like molecules is the search for molecules able to interfere with a protein function, since protein interactions control most biological processes. Ideally the use of in silico screenings would make drug development faster and less expensive. Currently, however, the confirmation of biological activity is still needed. Due to the complexity of the task of drug discovery, an integrated and multi-disciplinary approach is ultimately required. Here we discuss examples of drugs developed through a combination of in silico and in vitro strategies. The potential use of these methodologies for the identification of active compounds as well as for early toxicity and bioavailability is also reviewed.
Export Options
About this article
Cite this article as:
Pauli Ivani, Macedo Timmers Fernando Saraiva Luis, Caceres Andrade Rafael, Pereira Soares Botelho Milena and de Azevedo Jr. Filgueira Walter, In Silico and In Vitro: Identifying New Drugs, Current Drug Targets 2008; 9 (12) . https://dx.doi.org/10.2174/138945008786949397
DOI https://dx.doi.org/10.2174/138945008786949397 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design, Synthesis, Characterization and Bioactivity Evaluation of New Symmetric Disulfonamides and Dicarbamates of 4,4'-Oxydianiline
Anti-Infective Agents Effects of Myricitrin and Relevant Molecular Mechanisms
Current Stem Cell Research & Therapy Role of Glycosphingolipids and Therapeutic Perspectives on Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Improving Brain Drug Targeting Through Exploitation of The Nose-to- Brain Route: A Physiological and Pharmacokinetic Perspective
Current Drug Delivery Pharmacological Intervention at Ionotropic Glutamate Receptor Complexes
Current Pharmaceutical Design Thyroid Hormones and their Metabolites: Biological Roles and Association with Non-Alcoholic Fatty Liver Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Notoginsenoside R1 Promotes the Growth of Neonatal Rat Cortical Neurons via the Wnt/β-catenin Signaling Pathway
CNS & Neurological Disorders - Drug Targets Genetic Polymorphisms in Sigma-1 Receptor and Apolipoprotein E Interact to Influence the Severity of Alzheimers Disease
Current Alzheimer Research Nanomedicines for Brain Targeting: A Patent Review
Recent Patents on Nanomedicine Vascular Pathology from Smoking: Look at the Microcirculation!
Current Vascular Pharmacology Body Dysmorphic Disorder in Adolescents
Adolescent Psychiatry Treatment for Distress Associated with Accurate Appraisals of Self-Blame for Moral Transgressions
Current Psychiatry Reviews Curcumin, an Active Constiuent of the Ancient Medicinal Herb Curcuma longa L.: Some Uses and the Establishment and Biological Basis of Medical Efficacy
CNS & Neurological Disorders - Drug Targets The Effects of Drugs used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Pregnancy Outcome and Breast-feeding: A Critical Review
Current Neuropharmacology PDZ Domain Protein-Protein Interactions: A Case Study with PICK1
Current Topics in Medicinal Chemistry Development of Validated Stability Indicating HPTLC Method for the Estimation of Teriflunomide in Bulk and Tablet Dosage Form
Current Pharmaceutical Analysis Immunomodulatory Properties of Farnesoids: The New Steroids?
Current Medicinal Chemistry Enhanced Transdermal Delivery of Epidermal Growth Factor Facilitated by Dual Peptide Chaperone Motifs
Protein & Peptide Letters Small Molecule Neurotrophin Receptor Ligands: Novel Strategies for Targeting Alzheimers Disease Mechanisms
Current Alzheimer Research The Assessment of Attenuated Psychotic Symptoms in Adolescents: Concepts, Practical Approaches and Prediction of Risk
Adolescent Psychiatry